CVA Family Office’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
– Sell
-53
Closed -$482 – 1465
2024
Q4
$482 Buy
53
+48
+960% +$463 ﹤0.01% 1246
2024
Q3
$46 Hold
5
– – ﹤0.01% 1263
2024
Q2
$49 Hold
5
– – ﹤0.01% 1272
2024
Q1
$76 Hold
5
– – ﹤0.01% 1050
2023
Q4
$108 Buy
+5
New +$92 ﹤0.01% 1036
2023
Q3
– Sell
-5
Closed -$127 – 861
2023
Q2
$127 Buy
+5
New +$126 ﹤0.01% 1003

Other funds holding TDOC

CVA Family Office's TDOC Position: Q1 2025 in Review

CVA Family Office sold out of Teladoc Health (TDOC) in Q1 2025, closing a stake of 53 shares — an estimated $482 sold.

CVA Family Office first reported a position in TDOC in Q2 2023 and held it in 6 quarters. The position peaked at $482 in Q4 2024. 384 funds tracked by Wall St. Rank hold TDOC as of Q1 2025.

  • CVA Family Office reported no remaining Teladoc Health position as of Q1 2025 after selling out during the quarter.
  • CVA Family Office sold 53 Teladoc Health shares in Q1 2025, an estimated $482.
  • CVA Family Office first reported a position in Teladoc Health in Q2 2023 and held it in 6 quarters.
  • CVA Family Office's Teladoc Health position peaked at $482 in Q4 2024.
  • 384 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2025.

Based on CVA Family Office's 13F filing for Q1 2025, filed 16 Apr 2025.